Optimer Pharmaceuticals, Inc. (OPTR) – Hot FDA News
-
Optimer (OPTR) Says FDA Advisory Panel Votes to Recommend Fidaxomicin
-
FDA Advisory Panel Backs Safety, Effectiveness of Optimer's (OPTR) Fidaxomicin in 13-0 Vote
-
-
-
-
Back to OPTR Stock Lookup